CN1406600A - Medicine for hyperosteogeny - Google Patents
Medicine for hyperosteogeny Download PDFInfo
- Publication number
- CN1406600A CN1406600A CN 01127345 CN01127345A CN1406600A CN 1406600 A CN1406600 A CN 1406600A CN 01127345 CN01127345 CN 01127345 CN 01127345 A CN01127345 A CN 01127345A CN 1406600 A CN1406600 A CN 1406600A
- Authority
- CN
- China
- Prior art keywords
- medicine
- treatment
- hyperosteogeny
- pain
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A Chinese medicine for treating hyperosteogeny is prepared from 8 Chinese-medicinal materials including Dragon's blood, clematis root, ground beetle, Chinese angelica root, etc. Its advantages are high curative effect, no toxic by-effect, and low cost.
Description
The present invention relates to a kind of medicine, particularly a kind of medicine for the treatment of hyperosteogeny.
Clinical treatment hyperosteogeny method has non-operative treatment and operative treatment substantially at present.
Non-operative treatment parcel: physical therapy, vertebral body traction, Drug therapy, Chinese traditional treatment (parcel acupuncture, massage, cupping and force on etc.), doctor trained in Western medicine block therapy.
The defective that the non-operative treatment hyperosteogeny exists:
＜1〉physical therapy:, still, on physiology and pathology, all do not reach the purpose for the treatment of and effecting a radical cure hyperosteogeny though physical therapy can reach the purpose that eases the pain clinically.
＜2〉vertebral body traction: traction is better to the urgent effect of root compression.The main purpose of traction is that the friction and the compressing that alleviate lesions position help alleviating pain by the joint expansion, promotes human body to recover, obviously mitigation symptoms.But because of the vertebral body traction can only change the human body physical property, cause recurrence easily, make the state of an illness repeatedly.And the vertebral body traction is strongly professional because of technology, equipment, method etc., and the patient is difficult to grasp, and easily meets accident.Method is incorrect to be difficult to reach the treatment requirement.Cause patient's dizziness in the distraction procedure easily, even cause the head ischemia, rapid heart rate, serious made patient faints; Even cause vertebral body to dislocate and soft tissue injury.
＜3〉Drug therapy: clinically analgesic drug of using more, when doing physical therapy, traction, take some antipyretic-antalgic class medicines, as indometacin, ibuprofen, aspirin etc.These medicines can't reach suffers from the body requirement, is difficult to thoroughly remove ailing.Simultaneously, human body all there is in various degree infringement, has side effects.
＜4〉tcm therapy: acupuncture can alleviating pain, regulates the human body physiological function, promotes human body to grow metabolic balance, thereby eliminates or alleviate the sufferer process.But acupuncture belongs to advanced professional skill, and non-common people can grasp.Therefore, it is inter-household to need patient to come and go hospital, causes patient's inconvenience and painful, therefore is difficult to use.Studies have shown that massage can not be removed the cause of disease from physiology and pathology, and massage technique is stronger, need specialist to execute and control.Can only add the damage of re-organized as misapplication, pain is increased the weight of.The damage that may cause spinal column that has, even cause paralysis.Massage can only promote the blood circulation of tissue local, and is inoperative for other systemic factors that cause hyperosteogeny.Force on can only reach invigorate blood circulation, Shujin, change silt and aim of alleviating pain.But hyperosteogeny itself there is not therapeutical effect.
＜5〉doctor trained in Western medicine block therapy:
Thereby sealing can only make outgrowth sclerotin that tissue stimulation is alleviated alleviates local pain and discomfort.Therefore, can't remove the cause of disease, not reach therapeutic purposes.In addition, the block therapy improper use, even produce serious consequence.(as the wrong choice indication etc.), can cause and infect diffusion, malignant tumor is accelerated to shift, and organizes adverse consequencess such as ulceration and necrosis.And sealing drug dose concentration is difficult to hold.Be used to seal medicine and mostly be hormone medicine, this class medicine removes has antiinflammatory, outside the effects such as pain relieving and promotion tissue repair, causes tissue necrosis in addition, causes that infecting diffusion waits side effect.
Operative treatment: purpose is excision harm spinal cord and neural hypertrophy sclerotin, removes compressing, thereby eliminates symptom.But the operation technique difficulty is big, and dangerous high, expense is too high, and convalescent period is long.And operation can not change body metabolism and physiology and pathologic, postoperative easy infection and recurrence.
The object of the invention just provides a kind of symptom that can thoroughly remove various hyperosteogenys, does not recur.Make patient exempt the danger of operation; The deficiency of physical therapy; The risk of vertebral body traction; Exempt the adverse consequences that sealing causes; The side effect of analgesic; The inconvenience of Chinese traditional treatment and the consequence that might cause; Taking convenience, the hardship of exempting the Chinese herbal medicine decoction; Easy to carry, have no side effect; Expense is low and regulate from physiology and pathology, recovers the health regulatory function, makes metaboilic level recover the medicine of normal treatment hyperosteogeny
The object of the present invention is achieved like this; A kind of medicine for the treatment of hyperosteogeny, its special character are its raw material ratio (by weight): Agkistrodon 1-7%, Sanguis Draxonis 10-25%, Herba speranskiae tuberculatae 15-30%, Radix Clematidis 10-18%, eupolyphaga 10-20%, Herba Epimeredis Indicae 8-17%, Radix Angelicae Sinensis 9-16%.Utilize its biological characteristics dispeling disease and evil, eliminate the cause of disease; Recover the coordination of function, correct the pathological phenomenon that preponderance of either YIN or YANG declines partially, it is returned to normally to the full extent, reach therapeutic purposes.
The present invention can also add the Mel of 9-19% in above-mentioned prescription, utilize the medicinal properties of Mel, reaches better therapeutic effect.
Prescription medical material physiology medicinal properties of the present invention:
Agkistrodon: dispel the wind, active, arresting convulsion.Be applied to rheumatic arthralgia, the contracture of muscle arteries and veins; Facial hemiparalysis, numb limbs and tense tendons, apoplexy lower body are unsuccessful; Leprosy, stubborn dermatitis, skin pruritus; Tetanus, the anxious chronic infantile convulsion of children's etc.Stronger dispelling wind and removing obstruction in the collateral effect is arranged, forefathers Yun Qineng " the deep wind of searching cuts to shy and jerks surely ".
Sanguis Draxonis: the external hemostasia and promoting granulation is held back skin ulcer, promoting blood circulation to remove blood stasis pain relieving for oral administration.Traumatic hemorrhage, ulcer being unable to heal; Traumatic injury.In addition,, suffer from abdominal pain so can be used for women's blood stasis amenorrhea, dysmenorrhea, postpartum stagnation because of this product can eliminating stasis to stop pain, and disease such as all stagnation of blood stasis trusted subordinate twinges.
Radix Clematidis: wind-damp dispelling, the meridian dredging, stopping numbness pain is controlled a fishbone or other bone caught in the throat.Be used for rheumatic arthralgia, the pharynx of all a fishbone or other bone caught in the throat etc.
Radix Saposhnikoviae: expelling pathogenic wind from the body surface, win and wet, pain relieving, spasmolytic.Be used for the disease such as headache, general pain, aversion to cold due to the affection of exogenous wind-cold; Diseases such as anemofrigid-damp arthralgia, arthralgia, extremity contraction urgency; Diseases such as tetanus opisthotonus, gnathospasma, tic spasm.
Radix Angelicae Sinensis: enrich blood, invigorate blood circulation, pain relieving, intestine moistening.Be used for that all diseases of blood deficiency, menoxenia, amenorrhea, dysmenorrhea, asthenia cold abdominalgia, blood stasis are had a pain, traumatic injury, arthralgia pain numbness, ulcer sores, the constipation of blood deficiency dryness of the intestine
Eupolyphaga: removing blood stasis, reunion of fractured tendons and bones.Be used for amenorrhea, postpartum stagnation, lump in the abdomen; Fracture and injury, the stagnant pain of the stasis of blood reach diseases such as waist injury.
Mel: invigorating middle warmer emergency, nourishing the lung to arrest cough, laxation relieving constipation.The Compendium of Material Medica cloud: " merit that Mel is used as medicine has five: heat clearing away also, invigorating middle warmer also, detoxifcation is also moisturized also, pain relieving also.Living then cool in nature, so the energy heat clearing away; Ripe then warm in nature, so the energy invigorating middle warmer; Sweet and peaceful, so can detoxify; Soften and Ru Ze, so can moisturize; Slow then go urgency, so it is logical to end trusted subordinate's muscle skin infection; With can so that in, so can be in harmonious proportion hundred medicines and with the same merit of Radix Glycyrrhizae.”
Herba speranskiae tuberculatae: Tuberculate Speranskia Herb: function loose the wind damp eliminating, invigorate blood circulation, Shujin, pain relieving; Caulis Impatientis: function wind-damp dispelling, promoting blood circulation and stopping pain, detoxifcation; Cornu Caprae seu Ovis Herba speranskiae tuberculatae: function wind-damp dispelling, promoting blood circulation and stopping pain; The northeast Herba speranskiae tuberculatae: the function wind-damp dispelling, invigorate blood circulation, Shujin, pain relieving.
The present invention tests said medicine, and------medicine is processed in selected--dedusting---sterilization-use micronizing equipment then, to reduce the granularity of medicine, increases the absorption of medicine in health, improves the utilization rate of medicine in oven dry in screening just.After the micronizing, require to carry out mixing granulation, make semi-finished product, carry out the inspection of semifinished product according to prescription.Require to make capsule, tablet, powder according to preparation then.
----------the capsule fill--is packed--finished product--product inspection---warehouse-in (or dispatching from the factory) after the inspection of semifinished product to produce capsule.
Preparation tablets------------adds adjuvant and--mixes------wetting agent (or adhesive) system soft material----system granule----drying--chemical examination------granulate----tabletting--(coating)----quality examination-----packing after the micronizing.
Powder preparation----------divided dose--quality examination------packing after the inspection of semifinished product.
In addition, also can be made into pill or oral liquid etc., the treatment hyperosteogeny is had obvious effects.Use clinical treatment neck of the present invention, lumbar vertebra case 25 examples, (seeing Table 1) elbow, knee joint, hands, sufficient hypertrophy case 39 examples, (seeing Table 2) takes a course of treatment, and the course of disease alleviates 31 examples, produce effects case 26 examples, specially good effect 7 examples; Continued to take medicine second course of treatment, effective case 14 examples, produce effects case 32 examples, specially good effect case 15 examples are removed ailing 3 examples; After taking for the 3rd course of treatment, all cases are all removed slight illness.Tracing observation is not found recurrent cases.
Table 1: treatment lumbar and cervical vertebra hyperosteogeny patient effect table.
| The course of treatment | Effective number | Effective percentage | The produce effects number | Obvious effective rate | Specially good effect | The specially good effect rate | Recovery from illness | Cure rate |
| ????1 | ????12 | ????48％ | ????10 | ????40％ | ????3 | ????12％ | ????0 | ????0 |
| ????2 | ????0 | ????0 | ????15 | ????60％ | ????7 | ????28％ | ????3 | ????12％ |
| ????3 | ????0 | ????0 | ????0 | ????0 | ????0 | ????0 | ????25 | ????100％ |
Table 2: treatment patella ulnaris brothers hypertrophy patient effect table.
| The course of treatment | Effective number | Effective percentage | The produce effects number | Obvious effective rate | Specially good effect | The specially good effect rate |
| Take medicine a course of treatment | ????19 | ????48.7％ | ????16 | ????41％ | ????4 | ????10.3％ |
| Took medicine for two courses of treatment | ????14 | ????35.9％ | ????17 | ????43.6％ | ????8 | ????20.5％ |
| Took medicine for three courses of treatment | All patients all remove because of the pain that hypertrophy causes | |||||
As:
1: the fragrant woman of Sun Cui suffered from hyperosteogeny in 1992, went to a doctor repeatedly, did vertebra traction, acupuncture, massage; In in April, 93 two lower limb pain, numbness appear, unable to walk is walked to be admitted to hospital, the diagnosis lumbar vertebra causes spinal canal stenosis because of hypertrophy, dyskinesia occurs.Introduce through the doctor, take 1 course of treatment of our medicine, numbness alleviates, and two limb pains disappear substantially; Continued to take medicine 1 course of treatment, numb, pain all disappears, and the patient can normally walk; Continued to take medicine 1 course of treatment, in order to reinforce curative effect, recovery from illness.So far recurrence is seen at the end.
2: woods madam woman suffers from lumbar vertebra hyperosteogeny, and the sensation of movement dysfunction appears in pressuring nerve: crural paralysis loses locomotor activity; Insensitive, can not stand.Take 3 courses of treatment of this medicine, recover all functions, can normally walk, former paralysis disappears, and sensory function is good.
3: Sun Yan guest man suffered from lumbar vertebra hyperosteogeny in 97 years, ached in the back, and flank pain unbearably dare not be movable.Take medicine 3 courses of treatment, recover the waist function, pain disappears, and can normally work.So far do not see recurrence, curative effect is good.
4: the emerging man of Song Ji suffered from hyperosteogeny in 83 years.Flank pain is violent, is difficult to stand, and is stiff, and health is curled, and can not lie low.Be diagnosed as hyperosteogeny and cause spinal canal stenosis.Invalid through multi-treatment.After take 2 courses of treatment of this medicine, pain disappears, body movement, work is normal.Continue to take 1 course of treatment of this medicine, reinforce curative effect and do not see recurrence so far, can normally work.
5: Wang Zhi ring man suffers from hyperosteogeny: cervical region, back, shoulder pain.Point numb sometimes feeling numb.Be diagnosed as hyperosteogeny and oppressed the cervical nerves root.Take medicine after 3 courses of treatment, the numbness of the fingers sense disappears, and pain is eliminated.Cured the end recurrence 4 years.
6: Zhang Weinan is for a long time at the exquisite underground mining of being engaged in.Suffered from knee hyperplasia in 95 years, joint severe pain, redness, difficulty in walking can not be engaged in the down-hole work.Introduce through other patients, take 3 courses of treatment of this medicine, recover locomotor activity, can be engaged under the normal well and work.
7: the Wen Zhenjun man suffers from hyperosteogeny, and is dizzy weak, in short-term disturbance of consciousness.Take 3 courses of treatment of this medicine, above transference cure recovers operate as normal.
The invention will be further described below in conjunction with embodiment.
Embodiment 1: Agkistrodon 1.33% is pressed in the selected back of medicine; Sanguis Draxonis 14.1%; Herba speranskiae tuberculatae 28.19%; Radix Clematidis 14%; Eupolyphaga 14%; Herba Epimeredis Indicae 14.2%; The ratio of Radix Angelicae Sinensis 14.18% is made finished product according to manufacturing technique requirent.This kind prescription has good effect to lumbar vertebra, hyperosteogeny.To root compression compel or marrow in the caused neck-shoulder pain of hypertrophy, dizziness, blurring of vision, cardiopalmus, numbness of hand unable; Weakness of the lower extremities, numbness, paralysis, pain even paralysis have specially good effect.
Embodiment 2: Agkistrodon 2.56% is pressed in the selected back of medicine; Sanguis Draxonis 14.5%; Herba speranskiae tuberculatae 27.12%; Radix Clematidis 14.06%; Eupolyphaga 14.5%; Herba Epimeredis Indicae 14%; The ratio of Radix Angelicae Sinensis 13.26% is made finished product according to manufacturing technique requirent.This kind prescription is to hyperosteogeny and cause that various symptoms have good effect.
Embodiment 3: Agkistrodon 2% is pressed in the selected back of medicine; Sanguis Draxonis 18%; Herba speranskiae tuberculatae 25.55%; Radix Clematidis 13.6%; Eupolyphaga 15%; Herba Epimeredis Indicae 13%; The ratio of Radix Angelicae Sinensis 10.15% is made finished product according to manufacturing technique requirent.This kind prescription has good effect to the spinal canal stenosis symptom that hyperosteogeny causes
Embodiment 4: Agkistrodon 2.63% is pressed in the selected back of medicine; Sanguis Draxonis 13.9%; Herba speranskiae tuberculatae 27.8%; Radix Clematidis 13.9%; Eupolyphaga 13.9%; Herba Epimeredis Indicae 13.9%; The ratio of Radix Angelicae Sinensis 13.97% is made finished product according to manufacturing technique requirent.This kind prescription adversary, joints of foot hypertrophy symptom have good effect.
Embodiment 5: Agkistrodon 3.26% is pressed in the selected back of medicine; Sanguis Draxonis 19.4%; Herba speranskiae tuberculatae 25%; Radix Clematidis 12%; Eupolyphaga 18%; Herba Epimeredis Indicae 10%; The ratio of Radix Angelicae Sinensis 12.34% is made finished product according to manufacturing technique requirent.This kind prescription causes that to hyperosteogeny the various symptoms that spinal canal stenosis causes have good effect.
Embodiment 6: Agkistrodon 4% is pressed in the selected back of medicine; Sanguis Draxonis 21%; Herba speranskiae tuberculatae 18%; Radix Clematidis 11.44%; Eupolyphaga 13.2%; Herba Epimeredis Indicae 11%; Radix Angelicae Sinensis 12%; The ratio of Mel 9.36% is made finished product according to manufacturing technique requirent.This kind prescription has good effect to the various symptoms that elbow, knee hyperplasia cause.
Embodiment 7: Agkistrodon 1.8% is pressed in the selected back of medicine; Sanguis Draxonis 12.65%; Herba speranskiae tuberculatae 21.07%; Radix Clematidis 12.65%; Eupolyphaga 12.65; Herba Epimeredis Indicae 9.04%; Radix Angelicae Sinensis 12.04%; The ratio of Mel 18.1% is made finished product according to manufacturing technique requirent.This kind prescription has good effect to the various symptoms that hyperosteogeny causes.
Prescription science of the present invention has no side effect, and only needs hundreds of unit 1 course of treatment, and expense is low, is the good medicine of treatment hyperosteogeny.
Claims (3)
1. a medicine for the treatment of hyperosteogeny is characterized in that its raw material ratio (by weight): Agkistrodon 1-7%, Sanguis Draxonis 10-25%, Herba speranskiae tuberculatae 15-30%, Radix Clematidis 10-18%, eupolyphaga 10-20%, Herba Epimeredis Indicae 8-17%, Radix Angelicae Sinensis 9-16%.
2. a kind of medicine for the treatment of hyperosteogeny according to claim 1 is characterized in that its raw material ratio (by weight): Agkistrodon 1-5%, Sanguis Draxonis 13-22%, Herba speranskiae tuberculatae 17-29%, Radix Clematidis 11-16%, eupolyphaga 12-18%, Herba Epimeredis Indicae 9-15%, Radix Angelicae Sinensis 10-15%.
3. a kind of medicine for the treatment of hyperosteogeny according to claim 1 and 2 is characterized in that in its formula for raw stock adding the Mel of 9-19%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01127345 CN1406600A (en) | 2001-08-22 | 2001-08-22 | Medicine for hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01127345 CN1406600A (en) | 2001-08-22 | 2001-08-22 | Medicine for hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1406600A true CN1406600A (en) | 2003-04-02 |
Family
ID=4667310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01127345 Pending CN1406600A (en) | 2001-08-22 | 2001-08-22 | Medicine for hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1406600A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972379A (en) * | 2010-10-29 | 2011-02-16 | 荣成市新技术应用研究所 | Traditional Chinese medicinal composition for treating ostalgia |
| CN101979032A (en) * | 2010-10-26 | 2011-02-23 | 左权县蓝天中药科技开发有限公司 | Medicament for treating calcaneus spur hyperplasia |
| CN104922363A (en) * | 2015-07-16 | 2015-09-23 | 卢毅 | Traditional Chinese medicine composite for treating osteoproliferation |
-
2001
- 2001-08-22 CN CN 01127345 patent/CN1406600A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101979032A (en) * | 2010-10-26 | 2011-02-23 | 左权县蓝天中药科技开发有限公司 | Medicament for treating calcaneus spur hyperplasia |
| CN101972379A (en) * | 2010-10-29 | 2011-02-16 | 荣成市新技术应用研究所 | Traditional Chinese medicinal composition for treating ostalgia |
| CN104922363A (en) * | 2015-07-16 | 2015-09-23 | 卢毅 | Traditional Chinese medicine composite for treating osteoproliferation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103191382B (en) | Medicine for treating Bi syndrome and preparation method thereof | |
| CN100534480C (en) | Bone-setting medicine and preparation method thereof | |
| CN102228586B (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN101199723B (en) | Chinese medicine compound for oral administration for treating lumbar hyperosteogeny | |
| CN103055074A (en) | Traditional Chinese medicine ointment for treating hyperosteogeny and preparation method of traditional Chinese medicine ointment | |
| CN101385798B (en) | Wind dispelling and pain relieving paste | |
| CN104984183B (en) | A kind of fracture nursing drug | |
| CN104706749B (en) | A kind of Chinese medicine composition for treating lumbar vertebrae shoulder disc protrusion | |
| CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
| CN1406600A (en) | Medicine for hyperosteogeny | |
| CN101979032A (en) | Medicament for treating calcaneus spur hyperplasia | |
| CN104644928A (en) | Medicine for treating cervical and lumbar disc herniations | |
| CN1899564B (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN103340985A (en) | Medicine for reducing blood pressure and treating arthromyodynia | |
| CN108686146A (en) | A kind of Dressed plaster promoting blood circulation and removing blood stasis and preparation method thereof | |
| CN102755487A (en) | Traditional Chinese medicine powder for eliminating dampness and invigorating blood circulation | |
| CN108066572A (en) | A kind of plaster for treating gonarthromeningitis and preparation method thereof | |
| CN103157011B (en) | Traditional Chinese medicine composite for promoting fracture healing | |
| CN101204533B (en) | Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN100509052C (en) | Traditional Chinese medicine for treating bone medullitis | |
| CN105456329A (en) | Rheumatism pain alleviating medicinal liquor | |
| CN104013732A (en) | Soft capsules for treating rheumatoid diseases | |
| CN105193974B (en) | A kind of Chinese medicine composition that treating bone fracture disease and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |